Sava Infond d.o.o. Sells 850 Shares of UnitedHealth Group Incorporated $UNH

Sava Infond d.o.o. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,600 shares of the healthcare conglomerate’s stock after selling 850 shares during the quarter. Sava Infond d.o.o.’s holdings in UnitedHealth Group were worth $1,747,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Future Financial Wealth Managment LLC increased its stake in shares of UnitedHealth Group by 164.9% in the 2nd quarter. Future Financial Wealth Managment LLC now owns 1,486 shares of the healthcare conglomerate’s stock valued at $464,000 after acquiring an additional 925 shares during the last quarter. Hennessy Advisors Inc. bought a new stake in UnitedHealth Group during the 2nd quarter worth approximately $109,000. Ameriflex Group Inc. increased its stake in UnitedHealth Group by 5.0% during the 2nd quarter. Ameriflex Group Inc. now owns 1,938 shares of the healthcare conglomerate’s stock worth $587,000 after purchasing an additional 92 shares in the last quarter. ZWJ Investment Counsel Inc. increased its stake in UnitedHealth Group by 1.8% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,270 shares of the healthcare conglomerate’s stock worth $1,020,000 after purchasing an additional 59 shares in the last quarter. Finally, Successful Portfolios LLC increased its stake in UnitedHealth Group by 19.7% during the 2nd quarter. Successful Portfolios LLC now owns 1,311 shares of the healthcare conglomerate’s stock worth $409,000 after purchasing an additional 216 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Saturday, September 27th. Barclays raised their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, Truist Financial raised their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Price Performance

NYSE:UNH opened at $360.17 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a fifty day simple moving average of $307.84 and a 200 day simple moving average of $355.58. The stock has a market capitalization of $326.20 billion, a PE ratio of 15.61, a P/E/G ratio of 2.30 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.